In the evolving landscape of diabetes management, novel medications like semaglutide and retatrutide are gaining traction. These compounds, belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class, offer https://andrewdqhc209719.dbblog.net/12236621/semaglutide-vs-retatrutide-a-novel-comparison-in-diabetes-management